Literature DB >> 12427492

A longitudinal study of gastric emptying and upper gastrointestinal symptoms in patients with diabetes mellitus.

Karen L Jones1, Antonietta Russo, Melanie K Berry, Julie E Stevens, Judith M Wishart, Michael Horowitz.   

Abstract

PURPOSE: To evaluate the natural history of gastric emptying and upper gastrointestinal symptoms in patients with diabetes mellitus. SUBJECTS AND METHODS: We enrolled 20 patients (6 men, 14 women) with diabetes mellitus (16 with type 1 diabetes, 4 with type 2 diabetes). Each had measurements of gastric emptying of a solid (100 g of ground beef) and liquid (150 mL of 10% dextrose) meal using scintigraphy, glycemic control (glycosylated hemoglobin [HbA(1c)] and mean blood glucose levels), upper gastrointestinal symptoms, and autonomic nerve function at baseline and after a mean (+/- SD) of 12.3 +/- 3.1 years of follow-up.
RESULTS: There were no differences in mean gastric emptying of the solid component (retention at 100 minutes at baseline: 56% +/- 19% vs. follow-up: 51% +/- 21%, P = 0.23) or the liquid component (time for 50% to empty at baseline: 33 +/- 11 minutes vs. follow-up: 31 +/- 12 minutes, P = 0.71) during follow-up. Mean blood glucose (17.0 +/- 5.6 mmol/L vs. 13.8 +/- 4.9 mmol/L, P = 0.007) and HbA(1c) (8.4% +/- 2.3% vs. 7.6% +/- 1.3%, P = 0.03) levels were lower at follow-up. There was no difference in symptom score (baseline: 3.9 +/- 2.7 vs. follow-up: 4.2 +/- 4.0, P = 0.78). There was evidence of autonomic neuropathy in 7 patients (35%) at baseline and 16 (80%) at follow-up.
CONCLUSION: In patients with diabetes mellitus, we did not observe any marked changes in either gastric emptying or upper gastrointestinal symptoms during a 12-year period.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12427492     DOI: 10.1016/s0002-9343(02)01228-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  44 in total

1.  Gastroparesis: current concepts and management.

Authors:  Tatsuhiro Masaoka; Jan Tack
Journal:  Gut Liver       Date:  2009-09-30       Impact factor: 4.519

Review 2.  Epidemiology and natural history of gastroparesis.

Authors:  Adil E Bharucha
Journal:  Gastroenterol Clin North Am       Date:  2014-12-18       Impact factor: 3.806

3.  Acute effects of C-peptide on gastric emptying in longstanding type 1 diabetes.

Authors:  Julie E Stevens; Antonietta Russo; Carol A Delaney; Peter J Collins; Michael Horowitz; Karen L Jones
Journal:  Clin Auton Res       Date:  2006-02       Impact factor: 4.435

Review 4.  Gastroparesis--current concepts and considerations.

Authors:  William L Hasler
Journal:  Medscape J Med       Date:  2008-01-23

Review 5.  Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting.

Authors:  H P Parkman; M Camilleri; G Farrugia; R W McCallum; A E Bharucha; E A Mayer; J F Tack; R Spiller; M Horowitz; A I Vinik; J J Galligan; P J Pasricha; B Kuo; L A Szarka; L Marciani; K Jones; C R Parrish; P Sandroni; T Abell; T Ordog; W Hasler; K L Koch; K Sanders; N J Norton; F Hamilton
Journal:  Neurogastroenterol Motil       Date:  2009-12-09       Impact factor: 3.598

Review 6.  Gastroparesis: pathogenesis, diagnosis and management.

Authors:  William L Hasler
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-07-19       Impact factor: 46.802

Review 7.  Xiangshaliujunzi Decoction for the treatment of diabetic gastroparesis: a systematic review.

Authors:  Jia-Xing Tian; Min Li; Jiang-Quan Liao; Wen-Ke Liu; Xiao-Lin Tong
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

8.  Performance characteristics of scintigraphic measurement of gastric emptying of solids in healthy participants.

Authors:  M Camilleri; J Iturrino; A E Bharucha; D Burton; A Shin; I-D Jeong; A R Zinsmeister
Journal:  Neurogastroenterol Motil       Date:  2012-07-02       Impact factor: 3.598

9.  Gastric electrical stimulation: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2006-08-01

10.  Incretin-based therapies: new treatments for type 2 diabetes in the new millennium.

Authors:  Joan Khoo; Christopher K Rayner; Karen L Jones; Michael Horowitz
Journal:  Ther Clin Risk Manag       Date:  2009-08-20       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.